Unknown

Dataset Information

0

Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114.

ABSTRACT: TMC114 (darunavir) is a promising clinical inhibitor of HIV-1 protease (PR) for treatment of drug resistant HIV/AIDS. We report the ultra-high 0.84 A resolution crystal structure of the TMC114 complex with PR containing the drug-resistant mutation V32I (PR(V32I)), and the 1.22 A resolution structure of a complex with PR(M46L). These structures show TMC114 bound at two distinct sites, one in the active-site cavity and the second on the surface of one of the flexible flaps in the PR dimer. Remarkably, TMC114 binds at these two sites simultaneously in two diastereomers related by inversion of the sulfonamide nitrogen. Moreover, the flap site is shaped to accommodate the diastereomer with the S-enantiomeric nitrogen rather than the one with the R-enantiomeric nitrogen. The existence of the second binding site and two diastereomers suggest a mechanism for the high effectiveness of TMC114 on drug-resistant HIV and the potential design of new inhibitors.

SUBMITTER: Kovalevsky AY 

PROVIDER: S-EPMC1781337 | biostudies-literature | 2006 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114.

Kovalevsky Andrey Y AY   Liu Fengling F   Leshchenko Sofiya S   Ghosh Arun K AK   Louis John M JM   Harrison Robert W RW   Weber Irene T IT  

Journal of molecular biology 20060804 1

TMC114 (darunavir) is a promising clinical inhibitor of HIV-1 protease (PR) for treatment of drug resistant HIV/AIDS. We report the ultra-high 0.84 A resolution crystal structure of the TMC114 complex with PR containing the drug-resistant mutation V32I (PR(V32I)), and the 1.22 A resolution structure of a complex with PR(M46L). These structures show TMC114 bound at two distinct sites, one in the active-site cavity and the second on the surface of one of the flexible flaps in the PR dimer. Remarka  ...[more]

Similar Datasets

Unknown Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir.
| S-EPMC2253353 | biostudies-literature
Unknown Potent antiviral HIV-1 protease inhibitor combats highly drug resistant mutant PR20.
| S-EPMC7251940 | biostudies-literature
Unknown Capturing the reaction pathway in near-atomic-resolution crystal structures of HIV-1 protease.
| S-EPMC3476052 | biostudies-literature
Unknown Caught in the Act: the 1.5 A resolution crystal structures of the HIV-1 protease and the I54V mutant reveal a tetrahedral reaction intermediate.
| S-EPMC2546526 | biostudies-literature
Unknown Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization.
| S-EPMC151315 | biostudies-literature
Unknown Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
| S-EPMC47361 | biostudies-other
Unknown Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir.
| S-EPMC2771923 | biostudies-literature
Unknown HIV-1 protease mutations and protease inhibitor cross-resistance.
| S-EPMC2944562 | biostudies-literature
Unknown Deep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and protease.
| S-EPMC4404092 | biostudies-literature
Unknown Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.
| S-EPMC1781954 | biostudies-literature